Simultaneous determination of five different food proteins by high-performance liquid chromatography and partial least-squares multivariate calibration

A method is described for the simultaneous determination of food proteins originating from different raw food materials. The proteins are hydrolysed to amino acids which are labelled with dansyl chloride and finally separated by reversed-phase high-performance liquid chromatography. Partial least-squares multivariate calibration is used to resolve and quantify the overlapping amino-acid patterns. The method enables muscle protein, collagen, soy protein (both texturate and isolate), casein and milk protein to be quantified in both heated and raw samples from the same calibration set. The accuracies for the raw and heated samples averaged 3% and 6% relative total protein content, respectively.     

Gas chromatographic/mass spectrometric measurement of deuterium-labelled valine,leucine, isoleucine and phenylalanine in the human body

N-Trifluoroacetyl-n-butyl ester derivatives of deuterium-labelled valine, leucine, isoleucine and phenylulanine were analysed by the isotope dilution technique and gas chromatography/mass spectrometry (GC/MS). Selected ion retrieval and peak-area integration were applied. The conditions adopted gave good separations with a short experimental time and high intensity. Ratios of the total isotopic abundance and metabolic kinetic curves were obtained. The regression coefficient of the standard dilution curve was 0.99 and the relative standard deviation was 0.3%. The stabilities of the amino acid derivatives were also tested.     

Simultaneous determination of Al(III) and Fe(III) in post-hemodialysis fluids by spectrophotometry and multivariate calibration

A multivariate calibration model (PLS) was developed for the simultaneous spectrophotometric determination of Al(III) and Fe(III) in post-hemodialysis fluids with pyrocathecol violet (PCV) as chromogenic reagent. The analytes build stable complexes with PCV in presence of hexamine buffered medium at pH 6.1. The complexes show overlapped absorption bands in the spectral range of 220-800 nm so that absorptions of 580 wavelengths were necessary for the calibrations. Determinations of Al(III) and Fe(III) were done without masking agents. The best calibration model was obtained by using PLS-1 regression with three components after data mean centering. The spectrophotometric method applied to assay the analytes in real post-hemodialysis samples containing no desferrioxamine B presented good agreement with voltammetric measurements used as reference. Concentrations ranging from 0.20 to 0.60 mg L⁻¹ for Al(III) and for Fe(III) were determined in real samples. The multivariate detection limits for Al(III) and Fe(III) were 0.044 and 0.052 mg L⁻¹, respectively, and the calculated values of sensitivity were 6.33 for Al(III) and 3.44 for Fe(III). The proposed method showed to be straightforward and useful to follow the hemodialysis progress for patients under treatment. Interferents were also investigated.     

A simple and selective method for the measurement of leucine and isoleucine from plasma using electrospray ionization tandem mass spectrometry

An analytical method was developed for the rapid and accurate quantification of leucine (LEU) and isoleucine (ILE) from plasma using electrospray ionization tandem mass spectrometry (ESI-MS/MS). The two isomeric amino acids were selectively detected using fragment ions unique to each compound. As a result, the need for chromatographic separation was avoided allowing for faster analysis (3 min). The possibility of any considerable interference between the two transitions was closely monitored, with no significant interference being observed. The presence of interfering compounds in plasma was also evaluated and found to minimal. The method was evaluated based upon linearity, with r2>or=0.995 for both compounds, and accuracy, with no more than 8% deviation from the theoretical value.     

Separation of leucine and isoleucine by electrospray ionization-high field asymmetric waveform ion mobility spectrometry-mass spectrometry

An electrospray ionization (ESI) source was used to generate gas-phase molecular anions of the amino acids leucine and isoleucine ((M–H)⁻; m/z −130), which were separated by high- field asymmetric waveform ion mobility spectrometry (FAIMS) and detected by quadrupole mass spectrometry (MS). This combination of ESI-FAIMS-MS enabled selective determination of either amino acid in mixtures that contained at least a 625-fold excess of the other. Comparisons with conventional ESI-MS showed a 50-fold improvement in the signal to background ratio for a 1 μM solution of leucine.     

Simultaneous determination of atorvastatin calcium and ramipril in capsule dosage forms by high-performance liquid chromatography and high-performance thin layer chromatography

Two simple and accurate methods to determine atorvastatin calcium and ramipril in capsule dosage forms were developed and validated using HPLC and HPTLC. The HPLC separation was achieved on a Phenomenex Luna C18 column (250 x 4.6 mm id, 5 microm) in the isocratic mode using 0.1% phosphoric acid-acetonitrile (38 + 62, v/v), pH 3.5 +/- 0.05, mobile phase at a flow rate of 1 ml/min. The retention times were 6.42 and 2.86 min for atorvastatin calcium and ramipril, respectively. Quantification was achieved with a photodiode array detector set at 210 nm over the concentration range of 0.5-5 microg/mL for each, with mean recoveries (at three concentration levels) of 100.06 +/- 0.49% and 99.95 +/- 0.63% RSD for atorvastatin calcium and ramipril, respectively. The HPTLC separation was achieved on silica gel 60 F254 HPTLC plates using methanol-benzene-glacial acetic acid (19.6 + 80.0 + 0.4, v/v/v) as the mobile phase. The Rf values were 0.40 and 0.20 for atorvastatin calcium and ramipril, respectively. Quantification was achieved with UV densitometry at 210 nm over the concentration range of 50-500 ng/spot for each, with mean recoveries (at three concentration levels) of 99.98 +/- 0.75% and 99.87 +/- 0.83% RSD for atorvastatin calcium and ramipril, respectively. Both methods were validated according to International Conference on Harmonization guidelines and found to be simple, specific, accurate, precise, and robust. The mean assay percentages for atorvastatin calcium and ramipril were 99.90 and 99.55% for HPLC and 99.91 and 99.47% for HPTLC, respectively. The methods were successfully applied for the determination of atorvastatin calcium and ramipril in capsule dosage forms without any interference from common excipients.     

Direct analysis of dried blood spots by in-line desorption combined with high-resolution chromatography and mass spectrometry for quantification of maple syrup urine disease biomarkers leucine and isoleucine

A in-line desorption device was developed, which allows for direct analysis of dried blood spots eliminating the need for punching disks from the filter paper cards. Using this device, we have validated a method to quantify biomarkers related to maple syrup urine disease (MSUD), a metabolism disorder that often requires a second-tier test for confirmation. Direct analysis of newborn screening cards is conducted in-line with a high-resolution chromatographic separation with mass spectrometry using electrospray ionization and multiple-reaction monitoring. Quantification of leucine and isoleucine using an isotopically labeled internal standard encompasses a range suitable for MSUD assessment. Precision and accuracy of the technique was acceptable with relative standard deviations within 10% at three fortified concentrations and an unfortified level. A post-column infusion test shows minimum matrix suppression was observed using this direct sampling technique.     

Simultaneous determination of copper(II) and cobalt(II) by ion chromatography coupled with chemiluminescent detection.

In the absence of any special luminescent reagents, a weakly chemiluminescent emission was observed during the decomposition of hydrogen peroxide, catalyzed by transition-metal ions, such as Cu(II) and Co(II), in basic aqueous solution. The chemiluminescent intensity was significantly enhanced by the addition of ethyldimethylcetylammonium bromide and uranine. The signal-to-noise ratio (S/N) was proportional to the concentrations of Cu(II) and Co(II). Based on these phenomena, a flow-injection chemiluminescent method for the simultaneous separation and determination of Cu(II) and Co(II) was developed. The detection limits of the present chemiluminescent method for Cu(II) and Co(II) were 7.5 and 0.01 ng/ml, respectively. After ion chromatographic separation of Cu(II) and Co(II) by an IonPac CS5A column with oxalic acid and lithium hydroxide monohydrate as the eluent, the present chemiluminescent system was used as a post-column detector for these two transition metal ions in natural water samples.     

Simultaneous determination of chloroquine and selected calcium(II) channel blockers by high-performance liquid chromatography

Chloroquine (CQ), which is the primary drug for treatment and prophylaxis against malaria, has become ineffective because of the high prevalence of CQ-resistant P. falciparum parasites, but resistant parasites exposed to a Ca(II) channel blocker become as susceptible to CQ as sensitive parasites. A reversed-phase liquid chromatographic method is described for simultaneously determining CQ, its metabolites desethyl-CQ and bisdesethyl-CQ, the Ca(II) channel blocker verapamil, and the tiapamil analogue N-(3,4-dimethoxyphenethyl)- N-methyl-2-(naphthyl)-m-dithiane-2-propylamine hydrochloride. The analytes were separated by gradient elution with acetonitrile and 1-heptane sulfonic acid; the detector wavelength was 232 nm. The mean recovery from spiked plasma was 100.1 ± 2.28 (SD). Within-day retention times were reproducible to within ± 0.03 SD of mean values and the lower limit of detection was about 2 ng of each analyte.